Why is Parmax Pharma falling/rising?

As of 29-Sep, Parmax Pharma Ltd's stock price is currently at 33.05, reflecting a decrease of 0.65, or 1.93%. The stock has underperformed its sector by 2.07% today and has experienced a consecutive decline over the last two days, resulting in a total drop of 2.59% during this period. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. The delivery volume has also significantly decreased, with a 64.46% drop compared to the 5-day average, suggesting a decline in investor participation. There is no information available regarding positive or negative factors affecting the stock.
In the broader market context, Parmax Pharma's short-term performance over the past week shows a modest gain of 0.39%, contrasting with the Sensex, which has declined by 2.18%. However, over the past month, Parmax Pharma has underperformed significantly, with a decline of 6.88% compared to the Sensex's slight increase of 0.70%. Year-to-date, the stock has fallen by 25.31%, while the benchmark has risen by 2.85%. This stark contrast highlights the challenges faced by Parmax Pharma in the current market environment.